drugset / Trial / NCT07146347
Comparison Study of Insulin GZR4 With Insulin Degludec
Phase 1
Recruiting
14 enrolled
Gan and Lee Pharmaceuticals, USA
Profil Institut für Stoffwechselforschung GmbH · collab
NaSequentialOpen-labelTreatment
Summary
In this study, the investigational product will be compared with insulin degludec (Tresiba®) and insulin icodec (Awiqli®). The comparator products are approved for the treatment of T2DM in the European Union.
Timeline
- Start
- 2025-08-15
- Primary completion
- 2026-04-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZR4 | Unknown | — | — |